Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: ergotamine (Click to remove) Cluster Headache Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992 Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease NEJM 356:39-46, Zanettini,R.,et al, 2007 Dopamine Agonists and the Risk of Cardiac Valve Regurgitation NEJM 356:29-38, Schade,R.,et al, 2007 Cabergoline-Related Severe Restrictive Mitral Regurgitation NEJM 353:1974-1975, Rosen,C.J., 2005 Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease Lancet 363:1179-1183, Van Camp,G.,et al, 2004 Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide Neurol 61:859-861, VanCamp,G.,et al, 2003 Multiple Intracerebral Hemorrhages and Vasospasm Following Antimigrainous Drug Abuse Headache 38:478-480, Nighoghossian,N.,et al, 1998 Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992 Pleural and Retroperitoneal Fibrosis from Dihydroergotamine NEJM 321:1760, Malaquin,F.,et al, 1989 Bilateral Focal Cortical Atrophy & Chronic Ergotamine Abuse Neurol 35:720-722, Fincham,R.W.,et al, 1985 Carotidynia Neurol 27:43, Raskin,N.H.,et al, 1977 Transient Monocular Blindness Aspects of Neuro-Opthal, ed. by S. I. Davidson, 1974. , p. 103., Hutchinson,E.C., 1974 Showing articles 0 to 12 of 12